Current Assets 更改
AbbVie USD 33.22B 4.37B 2023-09
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Astellas Pharma JPY 1.12T 200.7B 2023-09
AstraZeneca USD 22.5B 338M 2023-09
Bluebird Bio USD 247.08M 40.9M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Emergent BioSolutions USD 777.7M 443.6M 2023-06
Exelixis USD 1.44B 147.16M 2023-09
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Heron Therapeutics USD 193.98M 28.7M 2023-09
Intrexon USD 92.99M 12.64M 2023-09
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06



Immunogen 流动资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.